lifestyle.luxedb.com

Author: NEKTAR THERAPEUTICS

Nektar Therapeutics to Participate in the Jefferies Global Healthcare Conference in London

November 2, 2025
Nektar to Announce Financial Results for the Third Quarter on Thursday, November 6, 2025, After Close of U.S.-Based Financial Markets

October 30, 2025
Data from REZOLVE-AD Phase 2b Study for Rezpegaldesleukin Accepted for Late-Breaking Oral Abstract Presentation at ACAAI 2025 Annual Scientific Meeting

October 27, 2025